Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
September 30, 2022
Our Mission
To make lives better by empowering consumers and simplifying the complex world of prescription drugs.
5440 W. 110th Street, Suite #200, Overland Park, KS 66211 • Pharmacy Support 1-800-268-4476 TTY: 1-800-877-8973 • Main Phone 913-815-3139 • Email [email protected]